Naturally occurring autoantibodies against alpha-synuclein rescues memory and motor deficits and attenuates alpha-synuclein pathology in mouse model of Parkinson's disease
文献类型:期刊论文
作者 | Huang, Ya-ru1,2; Xie, Xi-xiu1; Ji, Mei1,2; Yu, Xiao-lin1; Zhu, Jie1; Zhang, Ling-xiao1,2; Liu, Xiao-ge1,2; Wei, Chen3; Li, Gang4; Liu, Rui-tian1 |
刊名 | NEUROBIOLOGY OF DISEASE
![]() |
出版日期 | 2019-04-01 |
卷号 | 124页码:202-217 |
关键词 | Parkinson's disease alpha-Synuclein Naturally occurring autoantibodies A53T mice WIG |
ISSN号 | 0969-9961 |
DOI | 10.1016/j.nbd.2018.11.024 |
英文摘要 | It has been suggested that aggregation of alpha-synuclein (alpha-syn) into oligomers leads to neurodegeneration in Parkinson's disease (PD), but intravenous immunoglobulin (IVIG) which contains antibodies against alpha-syn monomers and oligomers fails to treat PD mouse model. The reason may be because IVIG contains much low level of antibodies against alpha-syn, and of which only a small part can penetrate the blood-brain barrier, resulting in an extremely low level of effective antibodies in the brain, and limiting the beneficial effect of IVIG on PD mice. Here, we first isolated naturally occurring autoantibodies against alpha-syn (NAbs-alpha-syn) from IVIG. Our further investigation results showed that NAbs-alpha-syn inhibited alpha-syn aggregation and attenuated alpha-syn-induced cytotoxicity in vitro. Compared with vehicles, NAbs-alpha-syn significantly attenuated the memory and motor deficits by reducing the levels of soluble alpha-syn, total human alpha-syn and alpha-syn oligomers, decreasing the intracellular P-alpha-syn(ser129) deposits and axonal pathology, inhibiting the microgliosis and astrogliosis, as well as the production of proinflammatory cytokines, increasing the levels of PSD95, synaptophysin and TH in the brain of A53T transgenic mice. These findings suggest that NAbs-alpha-syn overcomes the deficiency of IVIG and exhibits a promising therapeutic potential for the treatment of PD. |
WOS关键词 | INTRAVENOUS IMMUNOGLOBULIN ; ALZHEIMERS-DISEASE ; TRANSGENIC MODEL ; AGGREGATION ; IMMUNOTHERAPY ; ANTIBODIES ; OLIGOMERS ; MICE ; NEURODEGENERATION ; ACCUMULATION |
资助项目 | Strategic Leading Project of China Academy of Sciences[XDA 12040215] ; National Science and Technology Major Projects of New Drugs[2015ZX09102015] |
WOS研究方向 | Neurosciences & Neurology |
语种 | 英语 |
WOS记录号 | WOS:000459217800019 |
出版者 | ACADEMIC PRESS INC ELSEVIER SCIENCE |
资助机构 | Strategic Leading Project of China Academy of Sciences ; National Science and Technology Major Projects of New Drugs |
源URL | [http://ir.ipe.ac.cn/handle/122111/28086] ![]() |
专题 | 中国科学院过程工程研究所 |
通讯作者 | Li, Gang; Liu, Rui-tian |
作者单位 | 1.Chinese Acad Sci, Inst Proc Engn, Natl Key Lab Biochem Engn, Beijing 100190, Peoples R China 2.Univ Chinese Acad Sci, Sch Chem Engn, Beijing 100049, Peoples R China 3.Natl Inst Food & Drug Control, Beijing 100050, Peoples R China 4.Huazhong Univ Sci & Technol, Union Hosp, Dept Neurol, Tongji Med Coll, Jiefang Ave, Wuhan 430022, Hubei, Peoples R China |
推荐引用方式 GB/T 7714 | Huang, Ya-ru,Xie, Xi-xiu,Ji, Mei,et al. Naturally occurring autoantibodies against alpha-synuclein rescues memory and motor deficits and attenuates alpha-synuclein pathology in mouse model of Parkinson's disease[J]. NEUROBIOLOGY OF DISEASE,2019,124:202-217. |
APA | Huang, Ya-ru.,Xie, Xi-xiu.,Ji, Mei.,Yu, Xiao-lin.,Zhu, Jie.,...&Liu, Rui-tian.(2019).Naturally occurring autoantibodies against alpha-synuclein rescues memory and motor deficits and attenuates alpha-synuclein pathology in mouse model of Parkinson's disease.NEUROBIOLOGY OF DISEASE,124,202-217. |
MLA | Huang, Ya-ru,et al."Naturally occurring autoantibodies against alpha-synuclein rescues memory and motor deficits and attenuates alpha-synuclein pathology in mouse model of Parkinson's disease".NEUROBIOLOGY OF DISEASE 124(2019):202-217. |
入库方式: OAI收割
来源:过程工程研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。